Sy Mukherjee, Fortune

Sy Mukherjee

Fortune

New York, NY, United States

Contact Sy

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Fortune

Recent articles by Sy:

Brainstorm Health: Gottlieb Insulin Comments, Telehealth Apps, Actelion Settlement

Good afternoon, readers. Food and Drug Administration Commissioner (FDA) Scott Gottlieb isn’t exactly shy about speaking his mind on what he perceives are the pitfalls of American prescription drug policy. The agency chief didn’t break the habit on Tuesday, issuing a stern (and very long) missive against the skyrocketing price of insulin. “Today, insulin list prices regularly increase by double… → Read More

Brainstorm Health: Health Care Predictions, Diabetes Tests, Gilead CEO

Good afternoon, readers. We have a special treat for you today—Bob Kocher and Bryan Roberts, longtime health care venture gurus at Venrock, are back to offer even more of their unique wisdom on what we might expect in the health care world come 2019. I hope you take the time to read Bob’s and Bryan’s insightful analysis. I’ll be back with you tomorrow. Health Care Predictions for 2019 It is… → Read More

Moderna Had the Biggest Biotech IPO Ever. Here's What That Says About the Industry's Future

Moderna Therapeutics had an all-time record IPO, raising $604 million. Here's what that means for the future of biotech public offerings. → Read More

Brainstorm Health: Moderna Record IPO, Walgreens Prescription Delivery, Uterine Cancer Rise

Happy Friday, readers! Amid a rocky market that’s whipsawed on a near-daily basis, Moderna Therapeutics pulled off the improbable late Thursday: An historic IPO in which it raised more than $600 million. At a price of $23 per share, Moderna sold more than 26 million shares, setting up an approximately $7.5 billion valuation (although, amid the overall market turbulence and some important… → Read More

Brainstorm Health: CVS Benefits Change, Grail IPO, What Amazon and Location Say About Health

Hello and happy hump day, readers. With its $69 billion mega-merger with Aetna officially closed, pharmacy giant CVS is making one of its first major shakeups in its business structure after combining forces with the insurer, offering a new option to pass on 100% of drug rebates to its health plan sponsors (i.e., companies or organizations that sponsor health benefits for their employees and… → Read More

CVS Just Made a Big Change After Closing Its $69 Billion Aetna Deal. Here's What That Could Mean

CVS is already beginning to change its business structure in a post-Aetna deal world. → Read More

Brainstorm Health: U.S. Health Workers, FDA Liver Drug Guidance, Psychedelic Mushrooms

Good afternoon, readers. A new study published in JAMA on Tuesday highlights just how dependent the American health care work force is on foreign born workers. In fact, the study, an analysis of U.S. Census Bureau data, finds that nearly one third of U.S. physicians were born somewhere else. Some other striking figures from the analysis? Nearly 20% of health care workers across two dozen medical… → Read More

Brainstorm Health: GSK Tesaro Deal, VR Medical Education, Bluebird Bio

Hello, readers. I hope you had a wonderful weekend. On Monday, GlaxoSmithKline CEO Emma Walmsley made yet another significant mark on her company’s future, placing a $5.1 billion bet to acquire the cancer-focused biotech Tesaro. Tesaro stock soared 60% on the news while GSK shares slid 8% in Monday afternoon trading. The investor concerns are likely related to the hefty price Glaxo ponied up for… → Read More

Brainstorm Health: Editas CRISPR Study, Blood Pressure Drug Recalls, Measles and Ebola Outbreaks

Happy Friday, readers. There are many elements that influence the spread of infectious diseases. Cold, dry climates can propagate the flu; warmer, more humid ones can give rise to the mosquito populations that give transmit Zika or West Nile. But social factors are just as important to consider as environmental ones when it comes to communicable illness, as evidenced by two very different… → Read More

Brainstorm Health: Obamacare Waivers, AI and Human Emotions, China's Gene Editing Move

Good afternoon, readers. The Trump administration has taken another big whack at the Affordable Care Act (ACA), proposing regulations that could effectively allow states to seriously weaken the health law’s protections for Americans with pre-existing medical conditions. The rule changes had been hinted at before but officially released on Thursday. The proposals from the Centers for Medicare… → Read More

Brainstorm Health: Gene Editing Defense, Keto Diet Sensor, Rituxan Biosimilar

Good afternoon, readers. Earlier this week, stunning claims from Chinese scientist He Jiankui saying that the world’s first known, intentionally gene-edited babies had been born took the life sciences community by storm. Now, He is doubling down on the (still unverified) reported project, which has drawn criticism from a wide range of medical experts expressing ethical and practical concerns. He… → Read More

Brainstorm Health: Gene Edited Babies, Medical Device Overhaul, CVS Aetna Deal

Happy Monday, readers. I hope you had a wonderful Thanksgiving break. Let’s get back into it. A shock claim from a Chinese researcher saying that the world’s first known gene edited babies have been born is stirring major controversy among the life sciences community, drawing criticism from one of the pioneering minds behind CRISPR gene-editing tech itself and China’s Southern University of… → Read More

Brainstorm Health: Abortion Rates Plunge, Novartis Pear Therapeutics Collaboration, 3D Body Scanner

Happy Wednesday, readers. A bit of digital health news going into the Thanksgiving holiday. Vas Narasimhan, CEO of Swiss drug giant Novartis, has long telegraphed his interest in digital medicine. In one conversation I had with him a few years back (before he was elevated to his chief executive perch), Narasimhan waxed enthusiastic about the possibilities that artificial intelligence, remote… → Read More

Brainstorm Health: HIV Prevention Pill, Pfizer Price Hikes, Chickenpox Outbreak

Greetings, readers! On Tuesday, the U.S. Preventive Services Task Force (USPSTF), the government body tasked with, well, recommending preventive health care services to stop diseases in their tracks, is officially recommending that doctors prescribe prophylactic medicine to patients they consider vulnerable to contracting HIV. “The USPSTF recommends that clinicians offer pre-exposure prophylaxis… → Read More

Brainstorm Health: Peanut Allergy Drug, Tesaro Stock and Sale, Health Care Investments

Happy Monday, readers. I hope you had a wonderful weekend. Peanut allergies can be deadly—and a complicated practical issue to deal with, as anyone with personal experience with such an allergy (and there’s about one million kids in the U.S. who have one) well knows. But a new clinical trial suggests that the key to combating a life-threatening reaction may actually be, well, peanuts themselves.… → Read More

Brainstorm Health: Suicide Rates, AstraZeneca Cancer Miss, Alphabet's Glucose Lens Fail

Happy Friday, readers! In the digital health realm, it can be hard to balance hope versus hype, promise versus practicality. High aspirations and good intentions inevitably brush up against the cold light of scientific reality—all part of the process of science itself. Friday gave way to one small example of the constant tug-of-war in life sciences’ expectations game. And it involved two of the… → Read More

Brainstorm Health: Health Care Business Leaders, FDA E-Cigs Ban, Health Care on the Blockchain

Good afternoon, readers. This morning, Fortune unveiled our latest Businessperson of the Year list. It encompasses 20 individuals whose companies have delivered solid returns in profits, revenues, and stock growth (including over the past 12 months and three years)—and, in some instances, have some truly compelling backgrounds. You can check out the entire rankings here. But there are two health… → Read More

Brainstorm Health: Virta Health Diabetes Program, J&J Talc Suit, Precision Medicine

Hello and happy hump day, readers! Digital diabetes platforms have been among the biggest beneficiaries—and practical success stories—of the digital health revolution, as we’ve covered on a number of occasions. Now, one of the major players in the space, Virta Health, is really putting its money where its mouth is, tying financial reimbursements directly to whether or not its all-digital… → Read More

Brainstorm Health: Alcohol Abuse Screening, Juul Sales, SVB Leerink Merger

Good afternoon, readers. It’s no secret that the Food and Drug Administration (FDA) has been waging a battle against the tobacco and e-cigarette industries. And it’s having a practical effect. On Tuesday, the giant in the vaping space, Juul, officially announced that it would stop selling the majority of its reloadable, flavored nicotine pods from stores. And, perhaps even more significantly,… → Read More

Explaining Amarin's Fishy Stock Slide

Shares of Amarin fell Monday despite the fish oil drug Vascepa's apparent heart benefits. Here's why some investors were skittish. → Read More